Review article · 2012 · Open access

Challenges in Development of Nanoparticle-Based Therapeutics

Neil P. Desai

The AAPS Journal, 14(2), 282–295 · Published 9 March 2012 · DOI 10.1208/s12248-012-9339-4

Open PDFView at the publisherCite this paper

In brief

“Challenges in Development of Nanoparticle-Based Therapeutics” is a 2012 review article by Neil P. Desai, published in The AAPS Journal. OpenAlex counts 1,326 citations as of 20 November 2026, which puts it in the top 1% of works published in 2012 by citations. It is open access under a CC BY licence: the full text is free to read at The AAPS Journal.

Citations
1,326
Most cited in
2025 (239)
Field-weighted impact
2.04
References
89
Authors
1

Abstract

In recent years, nanotechnology has been increasingly applied to the area of drug development. Nanoparticle-based therapeutics can confer the ability to overcome biological barriers, effectively deliver hydrophobic drugs and biologics, and preferentially target sites of disease. However, despite these potential advantages, only a relatively small number of nanoparticle-based medicines have been approved for clinical use, with numerous challenges and hurdles at different stages of development. The complexity of nanoparticles as multi-component three dimensional constructs requires careful design and engineering, detailed orthogonal analysis methods, and reproducible scale-up and manufacturing process to achieve a consistent product with the intended physicochemical characteristics, biological behaviors, and pharmacological profiles. The safety and efficacy of nanomedicines can be influenced by minor variations in multiple parameters and need to be carefully examined in preclinical and clinical studies, particularly in context of the biodistribution, targeting to intended sites, and potential immune toxicities. Overall, nanomedicines may present additional development and regulatory considerations compared with conventional medicines, and while there is generally a lack of regulatory standards in the examination of nanoparticle-based medicines as a unique category of therapeutic agents, efforts are being made in this direction. This review summarizes challenges likely to be encountered during the development and approval of nanoparticle-based therapeutics, and discusses potential strategies for drug developers and regulatory agencies to accelerate the growth of this important field.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Desai, N. P. (2012). Challenges in Development of Nanoparticle-Based Therapeutics. The AAPS Journal, 14(2), 282–295. https://doi.org/10.1208/s12248-012-9339-4

MLA 9

Desai, Neil P. “Challenges in Development of Nanoparticle-Based Therapeutics.” The AAPS Journal, vol. 14, no. 2, 2012, pp. 282–295. https://doi.org/10.1208/s12248-012-9339-4.

Chicago

Desai, Neil P. 2012. “Challenges in Development of Nanoparticle-Based Therapeutics.” The AAPS Journal 14 (2): 282–295. https://doi.org/10.1208/s12248-012-9339-4.

Harvard

Desai, N. P. (2012) ‘Challenges in Development of Nanoparticle-Based Therapeutics’, The AAPS Journal, 14(2), pp. 282–295. doi:10.1208/s12248-012-9339-4.

IEEE

N. P. Desai, “Challenges in Development of Nanoparticle-Based Therapeutics,” The AAPS Journal, vol. 14, no. 2, pp. 282–295, 2012, doi: 10.1208/s12248-012-9339-4.

BibTeX

@article{desai2012challenges,
  title     = {{Challenges in Development of Nanoparticle-Based Therapeutics}},
  author    = {Desai, Neil P.},
  journal   = {The AAPS Journal},
  year      = {2012},
  volume    = {14},
  number    = {2},
  pages     = {282--295},
  doi       = {10.1208/s12248-012-9339-4},
  url       = {https://doi.org/10.1208/s12248-012-9339-4}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20177878
20187878
20197474
20207979
20216464
20227171
20238686
2024145145
2025239239
2026205205

Its field-weighted citation impact is 2.04: it has been cited 2.04 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • nanotherapeutics
  • nanomedicine development
  • drug delivery
  • hydrophobic drug delivery
  • targeted drug delivery
  • nanoparticle engineering
  • nanomedicine safety
  • tissue distribution

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Desai, N. P. (2012). Challenges in Development of Nanoparticle-Based Therapeutics. The AAPS Journal, 14(2), 282–295. https://doi.org/10.1208/s12248-012-9339-4

How many times has this paper been cited?

1,326 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The AAPS Journal: sign in and open the PDF from this page.

Who wrote this paper?

Neil P. Desai.

What is the DOI of this paper?

10.1208/s12248-012-9339-4, permanently at https://doi.org/10.1208/s12248-012-9339-4. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.